Solventum Corporation (SOLV) PS Ratio: 1.68
Is Solventum Corporation’s P/S ratio high or low?
Solventum Corporation's P/S ratio of 1.68 is 14% above its 2-year average of 1.48, near the high end of its 2-year range (1.01–1.80).
As of Friday, June 12, 2026. 7.99% above its 12-month average of 1.56.
SOLV PS Ratio Chart
SOLV Average PS Ratio Chart
SOLV Current vs Average PS Ratio Chart
SOLV PS Ratio Metrics
PS RATIO
1.68
PS RATIO AVG TTM
1.56
PS RATIO AVG 3Y
1.48
PS RATIO AVG 5Y
1.48
PS RATIO AVG 10Y
1.48
PS RATIO AVG 15Y
1.48
PS RATIO AVG 20Y
1.48
CURRENT VS TTM AVG
+7.99%
CURRENT VS 3Y AVG
+13.69%
CURRENT VS 5Y AVG
+13.69%
CURRENT VS 10Y AVG
+13.69%
CURRENT VS 15Y AVG
+13.69%
CURRENT VS 20Y AVG
+13.69%
SOLV Competitors' PS Ratio
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.72B | 1.68 | 1.56 | 1.48 | 1.48 |
| Align Technology, Inc. (ALGN) | $12.64B | 3.09 | 2.94 | 4.29 | 6.14 |
| Baxter International Inc. (BAX) | $10.58B | 0.93 | 1.00 | 1.30 | 1.80 |
| Hologic, Inc. (HOLX) | $16.97B | 4.16 | 3.83 | 4.27 | 3.99 |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | 2.29 | 2.13 | 2.36 | 3.07 |
| Tempus AI, Inc. (TEM) | $8.65B | 6.51 | 10.92 | 11.77 | 11.77 |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | 3.04 | 3.03 | 3.31 | 4.32 |
| Moderna, Inc. (MRNA) | $19.70B | 8.81 | 6.12 | 5.20 | 7.09 |
| Hims & Hers Health, Inc. (HIMS) | $6.19B | 2.68 | 4.52 | 4.20 | 4.37 |
| BioNTech SE (BNTX) | $22.39B | 6.63 | 7.56 | 6.75 | 5.47 |
P/S vs. its own history
At 1.68, P/S is richer than usual, sitting higher than 94% of its 2-year history.
2-year low
1.01
median
1.51
2-year high
1.80
Sales Valuation
P/S Ratio
1.68
Market Cap / Annual Revenue
Solventum Corporation PS Ratio Formula & Definition
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation PS Ratio FAQ
- What is the P/S ratio for Solventum Corporation (SOLV)?
- The P/S ratio for SOLV stock is 1.68.
- Is Solventum Corporation's P/S ratio high or low?
- Solventum Corporation's P/S ratio of 1.68 is 14% above its 2-year average of 1.48, near the high end of its 2-year range (1.01–1.80).
- What is the TTM average P/S ratio for Solventum Corporation (SOLV)?
- The TTM average P/S ratio for SOLV stock is 1.56.
- What is the 3Y average P/S ratio for Solventum Corporation (SOLV)?
- The 3Y average P/S ratio for SOLV stock is 1.48.
- What is the 5Y average P/S ratio for Solventum Corporation (SOLV)?
- The 5Y average P/S ratio for SOLV stock is 1.48.
- What is the 10Y average P/S ratio for Solventum Corporation (SOLV)?
- The 10Y average P/S ratio for SOLV stock is 1.48.
- What is the 15Y average P/S ratio for Solventum Corporation (SOLV)?
- The 15Y average P/S ratio for SOLV stock is 1.48.
- What is the 20Y average P/S ratio for Solventum Corporation (SOLV)?
- The 20Y average P/S ratio for SOLV stock is 1.48.
Solventum Corporation PS Ratio History
| DATE | PS RATIO |
|---|---|
| 2026-06-11 | 1.68 |
| 2026-06-10 | 1.72 |
| 2026-06-09 | 1.75 |
| 2026-06-08 | 1.67 |
| 2026-06-05 | 1.72 |
| 2026-06-04 | 1.75 |
| 2026-06-03 | 1.66 |
| 2026-06-02 | 1.62 |
| 2026-06-01 | 1.61 |
| 2026-05-29 | 1.59 |
| 2026-05-28 | 1.61 |
| 2026-05-27 | 1.61 |
| 2026-05-26 | 1.62 |
| 2026-05-22 | 1.63 |
| 2026-05-21 | 1.63 |
| 2026-05-20 | 1.62 |
| 2026-05-19 | 1.59 |
| 2026-05-18 | 1.62 |
| 2026-05-15 | 1.58 |
| 2026-05-14 | 1.58 |
| 2026-05-13 | 1.58 |
| 2026-05-12 | 1.60 |
| 2026-05-11 | 1.57 |
| 2026-05-08 | 1.56 |
| 2026-05-07 | 1.52 |
| 2026-05-06 | 1.51 |
| 2026-05-05 | 1.47 |
| 2026-05-04 | 1.42 |
| 2026-05-01 | 1.40 |
| 2026-04-30 | 1.42 |
| 2026-04-29 | 1.40 |
| 2026-04-28 | 1.42 |
| 2026-04-27 | 1.47 |
| 2026-04-24 | 1.44 |
| 2026-04-23 | 1.45 |
| 2026-04-22 | 1.46 |
| 2026-04-21 | 1.45 |
| 2026-04-20 | 1.47 |
| 2026-04-17 | 1.48 |
| 2026-04-16 | 1.45 |
| 2026-04-15 | 1.46 |
| 2026-04-14 | 1.45 |
| 2026-04-13 | 1.42 |
| 2026-04-10 | 1.39 |
| 2026-04-09 | 1.39 |
| 2026-04-08 | 1.37 |
| 2026-04-07 | 1.32 |
| 2026-04-06 | 1.33 |
| 2026-04-02 | 1.34 |
| 2026-04-01 | 1.36 |
| 2026-03-31 | 1.38 |
| 2026-03-30 | 1.34 |
| 2026-03-27 | 1.32 |
| 2026-03-26 | 1.36 |
| 2026-03-25 | 1.36 |
| 2026-03-24 | 1.35 |
| 2026-03-23 | 1.38 |
| 2026-03-20 | 1.39 |
| 2026-03-19 | 1.41 |
| 2026-03-18 | 1.41 |
| 2026-03-17 | 1.45 |
| 2026-03-16 | 1.41 |
| 2026-03-13 | 1.41 |
| 2026-03-12 | 1.39 |
| 2026-03-11 | 1.42 |
| 2026-03-10 | 1.42 |
| 2026-03-09 | 1.44 |
| 2026-03-06 | 1.46 |
| 2026-03-05 | 1.49 |
| 2026-03-04 | 1.48 |
| 2026-03-03 | 1.49 |
| 2026-03-02 | 1.54 |
| 2026-02-27 | 1.56 |
| 2026-02-26 | 1.61 |
| 2026-02-25 | 1.57 |
| 2026-02-24 | 1.53 |
| 2026-02-23 | 1.52 |
| 2026-02-20 | 1.52 |
| 2026-02-19 | 1.54 |
| 2026-02-18 | 1.56 |
| 2026-02-17 | 1.54 |
| 2026-02-13 | 1.58 |
| 2026-02-12 | 1.59 |
| 2026-02-11 | 1.70 |
| 2026-02-10 | 1.68 |
| 2026-02-09 | 1.63 |
| 2026-02-06 | 1.63 |
| 2026-02-05 | 1.61 |
| 2026-02-04 | 1.60 |
| 2026-02-03 | 1.58 |
| 2026-02-02 | 1.61 |
| 2026-01-30 | 1.61 |
| 2026-01-29 | 1.60 |
| 2026-01-28 | 1.60 |
| 2026-01-27 | 1.62 |
| 2026-01-26 | 1.65 |
| 2026-01-23 | 1.65 |
| 2026-01-22 | 1.68 |
| 2026-01-21 | 1.68 |
| 2026-01-20 | 1.65 |
| 2026-01-16 | 1.66 |
| 2026-01-15 | 1.68 |
| 2026-01-14 | 1.67 |
| 2026-01-13 | 1.67 |
| 2026-01-12 | 1.79 |
| 2026-01-09 | 1.80 |
| 2026-01-08 | 1.79 |
| 2026-01-07 | 1.76 |
| 2026-01-06 | 1.74 |
| 2026-01-05 | 1.69 |
| 2026-01-02 | 1.65 |
| 2025-12-31 | 1.65 |
| 2025-12-30 | 1.67 |
| 2025-12-29 | 1.67 |
| 2025-12-26 | 1.68 |
| 2025-12-24 | 1.67 |
| 2025-12-23 | 1.68 |
| 2025-12-22 | 1.69 |
| 2025-12-19 | 1.70 |
| 2025-12-18 | 1.68 |
| 2025-12-17 | 1.67 |
| 2025-12-16 | 1.68 |
| 2025-12-15 | 1.71 |
| 2025-12-12 | 1.73 |
| 2025-12-11 | 1.73 |
| 2025-12-10 | 1.71 |
| 2025-12-09 | 1.67 |
| 2025-12-08 | 1.72 |
| 2025-12-05 | 1.78 |
| 2025-12-04 | 1.78 |
| 2025-12-03 | 1.78 |
| 2025-12-02 | 1.79 |
| 2025-12-01 | 1.79 |
| 2025-11-28 | 1.78 |
| 2025-11-26 | 1.78 |
| 2025-11-25 | 1.79 |
| 2025-11-24 | 1.74 |
| 2025-11-21 | 1.73 |
| 2025-11-20 | 1.66 |
| 2025-11-19 | 1.61 |
| 2025-11-18 | 1.61 |
| 2025-11-17 | 1.59 |
| 2025-11-14 | 1.58 |
| 2025-11-13 | 1.57 |
| 2025-11-12 | 1.54 |
| 2025-11-11 | 1.54 |
| 2025-11-10 | 1.50 |
| 2025-11-07 | 1.49 |
| 2025-11-06 | 1.38 |
| 2025-11-05 | 1.41 |
| 2025-11-04 | 1.43 |
| 2025-11-03 | 1.42 |
| 2025-10-31 | 1.44 |
| 2025-10-30 | 1.45 |
| 2025-10-29 | 1.46 |
| 2025-10-28 | 1.48 |
| 2025-10-27 | 1.50 |
| 2025-10-24 | 1.49 |
| 2025-10-23 | 1.51 |
| 2025-10-22 | 1.52 |
| 2025-10-21 | 1.52 |
| 2025-10-20 | 1.52 |
| 2025-10-17 | 1.51 |
| 2025-10-16 | 1.49 |
| 2025-10-15 | 1.49 |
| 2025-10-14 | 1.49 |
| 2025-10-13 | 1.48 |
| 2025-10-10 | 1.47 |
| 2025-10-09 | 1.50 |
| 2025-10-08 | 1.51 |
| 2025-10-07 | 1.51 |
| 2025-10-06 | 1.54 |
| 2025-10-03 | 1.55 |
| 2025-10-02 | 1.56 |
| 2025-10-01 | 1.53 |
| 2025-09-30 | 1.52 |
| 2025-09-29 | 1.51 |
| 2025-09-26 | 1.49 |
| 2025-09-25 | 1.47 |
| 2025-09-24 | 1.50 |
| 2025-09-23 | 1.53 |
| 2025-09-22 | 1.54 |
| 2025-09-19 | 1.54 |
| 2025-09-18 | 1.55 |
| 2025-09-17 | 1.55 |
| 2025-09-16 | 1.55 |
| 2025-09-15 | 1.53 |
| 2025-09-12 | 1.53 |
| 2025-09-11 | 1.54 |
| 2025-09-10 | 1.49 |
| 2025-09-09 | 1.52 |
| 2025-09-08 | 1.56 |
| 2025-09-05 | 1.52 |
| 2025-09-04 | 1.51 |
| 2025-09-03 | 1.49 |
| 2025-09-02 | 1.50 |
| 2025-08-29 | 1.53 |
| 2025-08-28 | 1.52 |
| 2025-08-27 | 1.52 |
| 2025-08-26 | 1.52 |
| 2025-08-25 | 1.52 |
| 2025-08-22 | 1.54 |
| 2025-08-21 | 1.50 |
| 2025-08-20 | 1.52 |
| 2025-08-19 | 1.51 |
| 2025-08-18 | 1.48 |
| 2025-08-15 | 1.49 |
| 2025-08-14 | 1.53 |
| 2025-08-13 | 1.55 |
| 2025-08-12 | 1.51 |
| 2025-08-11 | 1.50 |
| 2025-08-08 | 1.53 |
| 2025-08-07 | 1.50 |
| 2025-08-06 | 1.53 |
| 2025-08-05 | 1.52 |
| 2025-08-04 | 1.54 |
| 2025-08-01 | 1.51 |
| 2025-07-31 | 1.50 |
| 2025-07-30 | 1.54 |
| 2025-07-29 | 1.55 |
| 2025-07-28 | 1.55 |
| 2025-07-25 | 1.57 |
| 2025-07-24 | 1.56 |
| 2025-07-23 | 1.57 |
| 2025-07-22 | 1.53 |
| 2025-07-21 | 1.52 |
| 2025-07-18 | 1.54 |
| 2025-07-17 | 1.55 |
| 2025-07-16 | 1.54 |
| 2025-07-15 | 1.55 |
| 2025-07-14 | 1.56 |
| 2025-07-11 | 1.55 |
| 2025-07-10 | 1.60 |
| 2025-07-09 | 1.56 |
| 2025-07-08 | 1.58 |
| 2025-07-07 | 1.60 |
| 2025-07-03 | 1.65 |
| 2025-07-02 | 1.65 |
| 2025-07-01 | 1.64 |
| 2025-06-30 | 1.60 |
| 2025-06-27 | 1.59 |
| 2025-06-26 | 1.57 |
| 2025-06-25 | 1.58 |
| 2025-06-24 | 1.58 |
| 2025-06-23 | 1.54 |
| 2025-06-20 | 1.55 |
| 2025-06-18 | 1.53 |
| 2025-06-17 | 1.53 |
| 2025-06-16 | 1.57 |
| 2025-06-13 | 1.55 |
| 2025-06-12 | 1.56 |
| 2025-06-11 | 1.57 |
| 2025-06-10 | 1.59 |
| 2025-06-09 | 1.58 |
| 2025-06-06 | 1.57 |
| 2025-06-05 | 1.59 |
| 2025-06-04 | 1.58 |
| 2025-06-03 | 1.56 |
| 2025-06-02 | 1.54 |
| 2025-05-30 | 1.54 |
Showing the most recent 260 of 555 data points. The chart above shows the full history.
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson